Chinese expert consensus on management of dyslipidemia in the elderly / 中华内科杂志
Chinese Journal of Internal Medicine
; (12): 1095-1118, 2022.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-957673
Responsible library:
WPRO
ABSTRACT
Dyslipidemia is an important risk factor of atherosclerotic cardiovascular disease (ASCVD). Statins delay the occurrence and development of ASCVD, and reduce the risk of cardiovascular events and death. Due to safety concerns, there exist insufficient use of lipid-lowering agents and a high withdrawal rate of the agents in the elderly. To promote the prevention and treatment of ASCVD, this expert consensus is issued and focuses on the management of dyslipidemia of Chinese elderly basing on the clinical evidence of the use of lipid-lowering drugs by the elderly, and the lipid management guidelines and expert consensus recommendations at home and abroad.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Internal Medicine
Year:
2022
Document type:
Article